Evidence map›Paper›PMID 30804000›Full record

ArticleThe Journal of experimental medicine2019

Discovery of

Peter Reinink, Jeffrey Buter, Vivek K Mishra, Eri Ishikawa, Tan-Yun Cheng, Peter T J Willemsen, Steffen Porwollik, Patrick J Brennan, Eva Heinz, Jacob A Mayfield and 9 more

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Approaches to stereoselective 1,1'-glycosylation.Beilstein journal of organic chemistry · 2025
    Review
  5. Understanding the role of trehalose in interactions betweenFrontiers in cellular and infection microbiology · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Quantitative Imaging of BiochemistryACS central science · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Commented on by
    "2019
5 · Who and what money

Authors and funding

19 authors.

Peter ReininkDepartment of Infectious Diseases and Immunology, School of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.ORCID 0000-0002-9836-1335
Jeffrey ButerDepartment of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA.ORCID 0000-0002-4440-6702
Vivek K MishraStratingh Institute for Chemistry, University of Groningen, Groningen, Netherlands.ORCID 0000-0002-2121-6121
Eri IshikawaDepartment of Molecular Immunology, Immunology Frontier Research Center, Osaka University, Osaka, Japan.
Tan-Yun ChengDepartment of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA.ORCID 0000-0002-5178-6985
Peter T J WillemsenWageningen Bioveterinary Research, Department of Infection Biology, Lelystad, Netherlands.
Steffen PorwollikDepartment of Microbiology and Molecular Genetics, University of California, Irvine, Irvine, CA.
Patrick J BrennanDepartment of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA.
Eva HeinzWellcome Trust Sanger Institute, Hinxton, UK.ORCID 0000-0003-4413-3756
Jacob A MayfieldDepartment of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA.
Gordon DouganWellcome Trust Sanger Institute, Hinxton, UK.ORCID 0000-0003-0022-965X
Cécile A van ElsCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Vincenzo CerundoloMRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID 0000-0003-0040-3793
Giorgio NapolitaniMRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Sho YamasakiDepartment of Molecular Immunology, Immunology Frontier Research Center, Osaka University, Osaka, Japan.
Adriaan J MinnaardStratingh Institute for Chemistry, University of Groningen, Groningen, Netherlands.ORCID 0000-0002-5966-1300
Michael McClellandDepartment of Microbiology and Molecular Genetics, University of California, Irvine, Irvine, CA.
D Branch MoodyDepartment of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA.ORCID 0000-0003-2306-3058
Ildiko Van RhijnDepartment of Infectious Diseases and Immunology, School of Veterinary Medicine, Utrecht University, Utrecht, Netherlands i.vanrhijn@uu.nl.ORCID 0000-0002-1446-5701

Funding

Molecular determinants of oxidative stress in Salmonella pathogenesisR01AI136520 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Andres Vazquez-Torres · 2018 to 2026
$3.7M
Role of Tuberculosinyl Metabolites in M. Tuberculosis VirulenceR01AI116604 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH · 2015 to 2019
$2.4M
Cancer Research UK C399/A2291Department of HealthMedical Research Council MC_UU_00008/1Medical Research Council MR/K021222/1NIAID NIH HHS HHSN272200900040CNIAID NIH HHS R01 AI116604NIAID NIH HHS R01 AI136520
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsCell MembraneEscherichia coliFecesHumansLectins, C-TypeMembrane ProteinsMiceMycobacteriumPhospholipidsPhylogenyReceptors, ImmunologicSalmonella typhiTransferases (Other Substituted Phosphate Groups)TrehaloseTyphoid Fevercardiolipin synthetaseCLEC4D protein, humanClecsf8 protein, mouseLectins, C-TypeMembrane ProteinsPhospholipidsReceptors, ImmunologicTransferases (Other Substituted Phosphate Groups)Trehalose

Identifiers

PMID30804000
PMCPMC6446866

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.